2022
DOI: 10.1016/j.fastrc.2022.100169
|View full text |Cite
|
Sign up to set email alerts
|

Amniotic membrane/ umbilical cord particulate injection for achilles tendinopathy with or without a partial tear

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 9 publications
(16 reference statements)
0
0
0
Order By: Relevance
“…There has been no prior clinical investigation to treat IC/BPS with micronized AM intradetrusor injection. However micronized AM has proven utility in various musculoskeletal applications including osteoarthritis, plantar fasciitis, tendinitis, and neuropathy recovery [7][8][9][10]. Similarly, our data demonstrates significantly improved voiding symptoms and bladder pain in patients for at least 3 months, but longer follow-up is crucial for the evaluation of clinical durability.…”
Section: Discussionsupporting
confidence: 59%
“…There has been no prior clinical investigation to treat IC/BPS with micronized AM intradetrusor injection. However micronized AM has proven utility in various musculoskeletal applications including osteoarthritis, plantar fasciitis, tendinitis, and neuropathy recovery [7][8][9][10]. Similarly, our data demonstrates significantly improved voiding symptoms and bladder pain in patients for at least 3 months, but longer follow-up is crucial for the evaluation of clinical durability.…”
Section: Discussionsupporting
confidence: 59%